Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dow/Danforth biotechnology deal

Dow AgroSciences has entered into a non-exclusive sublicensing deal with the US Donald Danforth Plant Science Center for the use of gene expression technology in the development of genetically modified disease-resistant cassava. The technology was developed by the US Scripps Research Institute and licensed exclusively to Dow. The Danforth group is developing cassava with resistance to cassava mosaic virus and cassava brown streak disease. Dow began collaborating on the project group in early 2010 ( Agrow No 584, p 3).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG004960

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel